Recently published research from Business Monitor International, "Kuwait Pharmaceuticals & Healthcare Report Q2 2014", is now available at Fast Market Research

Boston, MA -- (ReleaseWire) -- 04/15/2014 --With the Kuwaiti government's continued commitment to austerity, spending on healthcare provision for expatriate workers (which forms nearly two-thirds of its population) is going to be thoroughly scrutinised. New hospitals are being planned for expatriate workers and infrastructure development will continue to be a key area of growth, in addition to opportunities for private healthcare insurance providers to serve the expatriate market. The government's focus on non-communicable disease control will continue to provide lucrative opportunities for pharmaceutical companies.

View Full Report Details and Table of Contents

Headline Expenditure Projections

- Pharmaceuticals: KWD290mn (US$1.03bn) in 2013 to KWD306mn (US$1.10bn) in 2014; +5.6% in local currency terms and +6.8% in US dollar terms. Forecast raised to +6.8% in US$ terms for 2014.
- Healthcare: KWD1.50bn (US$5. 35bn) in 2013 to KWD1.67bn (US$6.00bn) in 2014; +10.9% in local currency terms and +12.1% in US dollar terms. Forecast raised to 12.1% in US$ terms for 2014.

Risk/Reward Rating

Kuwait scored 58.5 in BMI's Pharmaceutical Risk/Reward Rating (RRR) for Q214; a slight improvement in its score from Q413. Kuwait has risen to second place, behind Saudi Arabia, out of a total of 30 markets.

Key Trends And Developments

In February 2014, the system of allotting the morning/day shift to Kuwait citizens and GCC nationals, while allotting the evening shift to expatriates, is set to continue receiving approval from Dr Abdul Aziz Al- Farhood, the director of the Jahra District, the Arab Times reports. According to the paper, the system now applies to other health districts and evening shifts are also expected to be allotted to Bedouins. Earlier in January 2014, the Kuwaiti government terminated the services of 2,233 expatriate workers with conditions such as HIV AIDS and hepatitis C, and sent them back to their countries, the Arab Times reports.

In February 2014, Kuwait's Health Minister Ali Al-Obaidi during his visit to Turkey said that health cooperation between Turkey and Kuwait will be rewarding, particularly in the training of medical staff and joint investment in healthcare, reports the Arab Times.

In January 2014, the government renewed its focus on prevention of non-communicable diseases at the 39th session of the Health Ministers of Gulf Cooperation Council member states. The GCC ministers launched a programme to train staff in non-communicable disease control and established an award for excellence in disease combat.

BMI Economic View: We expect to see moderate economic growth in Kuwait, with real GDP growth of 2.9% in 2014, from of 3.0% in 2013. While lower gains in oil production will drag down headline GDP growth over the coming years, non-oil economic activity should remain relatively robust.

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Healthcare research reports at Fast Market Research

You may also be interested in these related reports:

- Sweden Pharmaceuticals & Healthcare Report Q2 2014
- Kenya Pharmaceuticals & Healthcare Report Q2 2014
- Croatia Pharmaceuticals & Healthcare Report Q2 2014
- Bangladesh Pharmaceuticals & Healthcare Report Q2 2014
- Mexico Pharmaceuticals & Healthcare Report Q2 2014
- Bulgaria Pharmaceuticals & Healthcare Report Q2 2014
- Thailand Pharmaceuticals & Healthcare Report Q2 2014
- Kazakhstan Pharmaceuticals & Healthcare Report Q2 2014
- Lebanon Pharmaceuticals & Healthcare Report Q2 2014
- Japan Pharmaceuticals & Healthcare Report Q2 2014